IGM Biosciences Inc

NASDAQ:IGMS   3:59:58 PM EDT
18.79
+1.28 (+7.31%)
Products, Mergers / Acquisitions

Sanofi and IGM Biosciences to collaborate in the sphere of oncology, IGM to receive $150 million upfront payments

Published: 03/29/2022 05:07 GMT
IGM Biosciences Inc (IGMS) - Press Release: Sanofi and Igm Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets.
And Igm Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets.
Igm to Receive $150 Million Upfront Payments, Potentially Over $6 Billion in Aggregate Development, Regulatory and Commercial Milestones.
/igm: Collaboration to Create, Develop, Manufacture and Commercialize New Class of Potential Therapeutics Combining Superior Features of Multi-valent Igm Antibodies Over Conventional Igg Antibodies for Stimulating Cell Surface Receptors.
Sanofi Has Also Expressed an Interest in Purchasing Up to $100m of Igm Non-voting Common Stock in a Public Financing.